Dermatology Excimer Laser Market – By Product Type, By Disease Type, By End Use - Global Forecast 2025 – 2034

Dermatology Excimer Laser Market Size

The global dermatology excimer laser market size was valued at around USD 609.6 million in 2024 and is expected to reach USD 1.6 billion by 2034, growing at a CAGR of 10.2% from 2025 to 2034. A dermatology excimer laser is a medical device that uses lens to focus an ultra-high intensity beam of ultraviolet light on specific skin areas that require treatment. Dermatology laser excimers operate at a wavelength of 308 nanometers, which ensures high degree of accuracy and precision with minimal damage to surrounding tissue.
 

In addition, the skin laser therapy is typically superficial and takes very little time. There is an increase in the demand for excimer lasers due to the growing cases of chronic dermatological disorders such as psoriasis, vitiligo, and atopic dermatitis. For instance, data from the International League of Dermatological Societies (ILDS) shows that as of 2022, around 223 million people were suffering from atopic dermatitis, out of which 43 million children were aged 1 to 4.
 

Moreover, NIH data indicates that in 2020, about 1.9 to 2.8 million adults in the U.S. had vitiligo, with global prevalence reaching up to 2%. These statistics highlight the significant burden of skin disorders worldwide and the need for effective treatment options. Beyond physical symptoms, patients also experience mental, emotional, and social challenges, further emphasizing the importance of effective treatments like excimer laser therapy.
 

Moreover, the development of excimer lasers for dermatology is being driven by their increased precision, safety, treatment efficiency and modern therapeutic features. Excimer lasers now utilize targeted phototherapy with a 308 nm laser that only affects the area of the skin which is marked. This is advantageous for the treatment of psoriasis, vitiligo, and atopic dermatitis. In addition, modern delivery systems ensure uniform energy distribution, improving patient comfort, reducing side effects of treatment, and allowing for better outcomes. For instance, GSD's Eximal Elite and DEKA’s Excilite μ systems use 308 nm excimer light for accurate and effective treatment, which enhances repigmentation and reduces negative side effects. Given the increasing number of patients suffering from dermatological conditions worldwide, these innovations will enhance market growth as they provide advanced treatment options that are safer and more effective.
 

Dermatology Excimer Laser Market Trends

• The combination of excimer lasers with topical calcineurin inhibitors is becoming increasingly common due to better repigmentation outcomes in vitiligo. This combined approach not only achieves higher repigmentation results compared to single treatment methods but also aligns with the growing trend toward personalized treatment, showing a shift toward more complete treatment approaches in dermatology care.
   
• According to research by the National Center for Biotechnology Information (NCBI), excimer laser therapy at 308 nm is less effective when used alone for vitiligo patients to achieve repigmentation. The research shows that when excimer laser treatment is used together with topical calcineurin inhibitors, the repigmentation results are much higher. They recommend that the best outcomes are achieved with at least 20 sessions given two to three times per week.
   
• Additionally, the increase in non-invasive and minimally invasive treatment options, along with improvements in excimer laser technology for vitiligo treatment, makes recovery faster with fewer side effects. This increases the use of excimer lasers in vitiligo treatment, both for medical and cosmetic purposes.
• Furthermore, excimer lasers are now more widely used in aesthetic dermatology, including skin rejuvenation and scar removal, beyond medical conditions. Their use in cosmetic treatments creates new business opportunities and reaches more patients.
   
• For example, Lumenis sells the UltraPulse CO2 laser system that uses excimer laser technology in advanced aesthetic medicine, such as skin rejuvenation and scar revision. The UltraPulse system treats acne, surgical, and aging scars by helping skin recovery and collagen production through laser energy.
   

Dermatology Excimer Laser Market Analysis

Based on product type, the market is divided into trolley mounted excimer lasers, handheld excimer lasers, and tabletop excimer lasers. The market was valued at USD 554.5 million in 2023 and is expected to reach USD 1.6 billion by 2034. In 2024, the trolley-mounted excimer laser segment accounted for largest revenue share of 45.6%.
 

• These devices are preferred because of their sturdy construction, easy transport, and precision in delivering intense UVB light to specific skin areas.
   
• According to the Mayo Clinic, excimer laser therapy requires fewer treatment sessions than traditional light therapy, expected to reach USD 1.5 billion by 2032, because it uses strong UVB light, making it effective for treating skin conditions.
   
• Also, the advances in technology and increased knowledge of skin disorders as well as the effective treatments have contributed to the leading position of this segment in the market.
   

Based on disease type, the dermatology excimer laser market is segmented into psoriasis, vitiligo, eczema/atopic dermatitis, allergic rhinitis, alopecia areata, and other diseases. The psoriasis segment dominated the market accounting for a share of 38.2% in 2024.
 

• The psoriasis segment held the largest share of market revenue due to the growing prevalence of skin disorders and the high demand for effective treatment options.
   

• According to the American Academy of Dermatology Association, there are approximately 7.5 million diagnosed patients suffering from psoriasis in the U.S. This significant number indicates a critical need for excimer laser therapy, which helps in psoriasis treatment and management of such chronic skin conditions.
   
• Excimer laser delivers UVB light to psoriasis lesions and provides treatment to the affected areas. The precision of treatment is a major factor that determines the success of treatment and recovery, which is why laser therapy is a popular choice among healthcare professionals and patients.
   
• Thus, in addition to the increasing need to treat psoriasis lesions, the effectiveness of excimer therapy as a non-invasive treatment, together with the rising demand, is fueling the growth in the segment.
   

Based on end use, the dermatology excimer laser market is segmented into hospitals, dermatology and cosmetic clinics, plastic surgery centers, and other end users. The dermatology and cosmetic clinics segment dominated the market accounting for USD 275.7 million 2024.
 

• Dermatology and cosmetic clinics are the preferred options for patients because these clinics offer greater accessibility, shorter appointment wait times, and lower procedural costs compared to other healthcare settings, making laser treatments more convenient for patients.
   
• The high demand for aesthetic procedures such as scar and pigmentation removal has increased the use of excimer lasers in these clinics. The attention to specific needs, innovative treatment techniques, and fast recovery times offered by these clinics make them appealing to patients from different backgrounds.
   
• Additionally, increasing disposable income and rising awareness of dermatological health have attracted more patients to dermatology and cosmetic clinics, further establishing them as market leaders.
   

North America: In 2024, the U.S. dermatology excimer laser market was valued at USD 228.7 million and is projected to grow at a CAGR of 10.2%, reaching USD 603.8 million by 2034.
 

• The increasing occurrence of chronic dermatological disorders such as psoriasis, vitiligo, allergic rhinitis, and atopic dermatitis is driving the need for dermatology excimer lasers in the U.S.
   
• According to the American College of Allergy, Asthma, and Immunology (ACAAI), allergic rhinitis affects approximately 40 million to 60 million people in the U.S., which supports the demand for effective treatment options such as dermatology excimer laser.
   
• Furthermore, improvements in excimer laser technologies have enhanced their efficiency and safety, increasing their acceptance as treatment options, which helps drive growth of the market within the country.
   

Europe: The dermatology excimer laser market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The introduction of new dermatology excimer laser systems with precise UVB light delivery systems, ergonomic controls, and compact excimer technologies by both domestic and international manufacturers is fostering market growth in the UK.
   
• In addition, the rise in healthcare consumerism is driven by patients suffering from eczema and vitiligo, increasing the number of patients utilizing excimer lasers in healthcare facilities. The National Eczema Society states that atopic eczema approximately affects 1 in 10 adults and 1 in 5 children in the UK.
   

Asia Pacific: Japan’s dermatology excimer laser market is anticipated to witness lucrative growth between 2025 and 2034.
 

• The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has strict guidelines for the safe use of excimer lasers in dermatology care, which makes these regulatory bodies have a high degree of control.
   
• For instance, Japan's adoption of advanced healthcare technologies is shown through the government's approval of advanced excimer devices, such as STRATA Skin Sciences' XTRAC Momentum 1.0. Japan is experiencing rapid growth in market value because of the rising adoption of these devices, which are used in more than 300 hospitals and clinics for treating different skin conditions.
   

Middle East and Africa: The dermatology excimer laser market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• The utilization of dermatology excimer lasers in Saudi Arabia is increasing due to greater awareness of treatment options for skin disorders and government programs aimed at improving the healthcare system.
   
• Also, the country faces an increasing prevalence of alopecia areata, which affects 2.3% to 5.2% of the population according to recent studies. These statistics of increasing skin conditions drive the demand for excimer lasers in the country.
   

Dermatology Excimer Laser Market Share

Alma Lasers, Kernel Medical Equipment, GSD - Global Skin Dermatologist, STRATA Skin Sciences, and LASEROPTEK are the top 5 companies leading the medical excimer laser for dermatology market with combined shares of about 40%. The competition is very fierce as it is both international and regional. Companies are focusing on improving the methods used to carry out treatment procedures to meet the increased demand for accuracy as well as compact and user-friendly devices that can fit diverse clinical environments. Strategic alliances with dermatology practices, research organizations, and other medical technology firms are important for product promotion and integrating them into several dermatological practices. By using such strategies, companies will remain competitive and achieve growth in the changing market.
 

Dermatology Excimer Laser Market Companies

Some of the eminent market participants operating in the dermatology excimer laser industry include:

• Alma Laser
• Beijing Sincoheren S&T Development
• DEKA Research & Development
• GSD - Global Skin Dermatologist
• Kernel Medical Equipment
• KRUPA MEDI SCAN
• LASEROPTEK
• Lumenis
• PhotoMedex 
• STRATA Skin Sciences
• The Daavlin Company
   
• Lumenis operates in over 100 countries, with a well-established distribution network across North America, Europe, and Asia-Pacific, ensuring wide accessibility to its excimer laser solutions for dermatological treatments.
   
• STRATA Skin Sciences is one of the leading companies in excimer laser technology, offering the XTRAC laser system, which is specifically designed for treating psoriasis, vitiligo, and other skin conditions with targeted UVB therapy, minimizing exposure to surrounding healthy skin. For instance, STRATA's XTRAC excimer laser has been used for over 10 million treatments worldwide, demonstrating its effectiveness in delivering targeted phototherapy for chronic dermatological conditions.
   

Dermatology Excimer Laser Industry News:

• In July 2024, XTRAC Momentum 1.0 device from STRATA Skin Sciences, Inc. was approved by Japan’s Ministry of Health, Labor and Welfare. The device was launched in the U.S in early 2022 and became available in Japan via STRATA’s partners JMEC Co. Ltd. STRATA’s excimer devices are used in over 300 hospitals and dermatology clinics across Japan. This approval broadened the company’s presence in Japan and increases advanced treatment options for skin conditions such as psoriasis and vitiligo.
   
• In August 2021, STRATA Skin Sciences, Inc. announced that they had acquired the U.S. dermatology division of Ra Medical Systems. This purchase consisted of Ra Medical's PHAROS excimer laser system which STRATA intended to add to their service offerings. The deal sought to strengthen STRATA’s capabilities in excimer laser therapy and deepen their reach in dermatology.
   
• In August 2020, LASEROPTEK Co. Ltd. announced its PALLAS Solid-State 311nm UVB laser had been launched in the U.S. The laser is cleared by the FDA to treat vitiligo, psoriasis, atopic dermatitis and leukoderma. In comparison with the conventional gas-based excimer lasers, PALLAS laser is strong return on investment due to its solid-state design which doesn’t use gas or electrodes. This launch is expected to strengthen LASEROPTEK’s position in the dermatology laser market by expanding its portfolio with innovative, cost-effective solutions.

The dermatology excimer laser market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Trolley mounted excimer lasers
• Handheld excimer lasers
• Tabletop excimer lasers

Market, By Disease Type

• Psoriasis
• Vitiligo
• Eczema/ atopic dermatitis
• Allergic rhinitis
• Alopecia areata
• Other diseases

Market, By End Use

• Hospitals
• Dermatology and cosmetic clinics
• Plastic surgery centers
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • Saudi Arabia
  • South Africa
  • UAE